NEW YORK (GenomeWeb News) – Shanghai Biochip is looking to move beyond its role as a contract research organization and into the molecular diagnostics market, according to an executive of the firm.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.